COVID in men vs women - could hormones have an effect on Covid-19?

The COVID Symptom Study today announces it will be working together with NHS England to facilitate key research into the potential protective effects of hormonal therapies like HRT or the pill COVID-19. 

More than 3 million people in the UK have provided data via the COVID Symptom Study app, launched by researchers at King’s College London and health technology company ZOE. This is the largest group of participants contributing to COVID-19 research in the world.

Please sign up for the app even if you’re completely well with daily reporting to contribute to the understanding of this terrible disease.

The COVID Symptom Study app has been updated to include specific questions about periods, hormone medications and menopause with the aim to better understand how hormones such as oestrogen might influence COVID-19 outcomes.

Dr Louise Newson, advisor to NHS England, GP and menopause specialist commented: “The COVID Symptom Study volunteers are an amazing resource that can answer a powerful question about the role of hormones in Covid-19 in a matter of days which can help the NHS save lives.”

Tim Spector, Professor of Genetic Epidemiology at King’s College London:

“We are really pleased to be working with NHS England and our millions of citizen scientists to help progress our understanding of COVID-19. It’s fantastic to see the COVID Symptom Study being used as a critical tool to enable NHS England to scale research projects at pace and ultimately help find a long term solution to this virus. 

Unlike the contact tracing app, the COVID Symptom Study is allowing users to be actively involved in the world’s largest science research project to help fight COVID. We welcome further opportunities to collaborate with the medical and scientific community to make even more progress in the fight against this deadly disease.”

 For the full press article, please click here